Jiangzhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000M80
CNY
25.83
-0.16 (-0.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,184.61
4,402.37
4,518.08
3,850.50
2,845.44
2,416.06
2,420.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,184.61
4,402.37
4,518.08
3,850.50
2,845.44
2,416.06
2,420.26
Raw Material Cost
1,511.67
1,670.10
1,698.55
1,428.05
1,066.45
880.36
856.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.64
2.16
7.85
5.04
3.88
2.20
0.31
Selling and Distribution Expenses
1,486.61
1,674.58
1,824.46
1,699.45
1,176.80
940.73
996.53
Other Expenses
13.26
11.10
11.00
7.92
7.01
4.14
3.65
Total Expenditure (Excl Depreciation)
3,133.57
3,457.87
3,640.87
3,211.77
2,317.18
1,864.72
1,889.50
Operating Profit (PBDIT) excl Other Income
1051
944.5
877.2
638.6999999999999
528.3
551.3000000000001
530.8
Other Income
162.41
137.28
118.22
76.95
63.68
67.23
41.73
Operating Profit (PBDIT)
1,334.87
1,172.25
1,084.20
820.50
686.90
708.97
665.53
Interest
2.64
2.16
7.85
5.04
3.88
2.20
0.31
Exceptional Items
33.49
-5.75
-30.43
61.09
58.88
-5.68
17.34
Gross Profit (PBDT)
2,672.95
2,732.27
2,819.53
2,422.45
1,778.99
1,535.70
1,564.11
Depreciation
152.32
137.75
126.86
122.45
115.74
113.05
113.23
Profit Before Tax
1,213.39
1,026.59
919.06
754.10
626.16
588.04
569.34
Tax
225.17
165.11
129.11
106.89
92.19
89.07
86.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
906.69
788.19
718.67
598.24
505.69
473.74
463.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
906.69
788.19
718.67
598.24
505.69
473.74
463.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
80.87
72.31
68.34
48.15
25.26
16.58
15.84
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
987.55
860.51
787.01
646.39
530.95
490.32
479.44
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,022.81
3,862.81
3,909.77
3,903.53
4,003.03
3,876.87
3,560.63
Earnings per share (EPS)
1.44
1.26
1.15
0.96
0.8
0.75
0.74
Diluted Earnings per share
1.44
1.26
1.15
0.96
0.8
0.75
0.74
Operating Profit Margin (Excl OI)
24.38%
20.38%
18.57%
16.13%
17.83%
21.88%
21.1%
Gross Profit Margin
32.64%
26.45%
23.15%
22.76%
26.07%
29.02%
28.2%
PAT Margin
21.67%
17.9%
15.91%
15.54%
17.77%
19.61%
19.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -4.95% vs -2.56% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 14.77% vs 9.34% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 13.29% vs 7.14% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 18.18% vs -72.15% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Jiangzhong Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,184.61
0
4,184.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,184.61
0
4,184.61
Raw Material Cost
1,511.67
0
1,511.67
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.64
0
2.64
Selling and Distribution Expenses
1,486.61
0
1,486.61
Other Expenses
13.26
0.00
13.26
Total Expenditure (Excl Depreciation)
3,133.57
0
3,133.57
Operating Profit (PBDIT) excl Other Income
1,051.05
0.00
1,051.05
Other Income
162.41
0
162.41
Operating Profit (PBDIT)
1,334.87
0
1,334.87
Interest
2.64
0
2.64
Exceptional Items
33.49
0
33.49
Gross Profit (PBDT)
2,672.95
0
2,672.95
Depreciation
152.32
0
152.32
Profit Before Tax
1,213.39
0
1,213.39
Tax
225.17
0
225.17
Provisions and contingencies
0
0
0.00
Profit After Tax
906.69
0
906.69
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
906.69
0
906.69
Share in Profit of Associates
0
0
0.00
Minority Interest
80.87
0
80.87
Other related items
0.00
0.00
0.00
Consolidated Net Profit
987.55
0
987.55
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,022.81
0
4,022.81
Earnings per share (EPS)
1.44
0
1.44
Diluted Earnings per share
1.44
0
1.44
Operating Profit Margin (Excl OI)
24.38%
0%
0.00
24.38%
Gross Profit Margin
32.64%
0%
0.00
32.64%
PAT Margin
21.67%
0%
0.00
21.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 418.46 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.95% vs -2.56% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 98.76 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.77% vs 9.34% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 117.25 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.29% vs 7.14% in Dec 2024

Annual - Interest
Interest 0.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 18.18% vs -72.15% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.38%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024